Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva launches asthma social media campaign - PMLiVE
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
Qvar 100 inhaler (Teva UK Ltd) 200 dose - RightBreathe
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
Teva buys Gecko to add device and app to asthma and COPD drugs
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
Teva's DuoResp Spiromax wins silver at MDEA
Teva Inhalation Aerosol Approved by FDA for Children 4 and Over - Pharmaceutical Processing World
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva Announces FDA approval of AirDuo® Digihaler™
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva Launches 2 New Digital Maintenance Inhalers
Teva launches digital asthma and COPD rescue inhaler in US | pharmaphorum
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
